Administration of granulated BCAA and quality of life

Naohiro Kawamura; Hiroshi Nakajima; Shin-Ichi Takashi

doi:10.1016/j.hepres.2004.10.008

Administration of granulated BCAA and quality of life

Hepatol Res. 2004 Dec:30S:42-45. doi: 10.1016/j.hepres.2004.10.008.

Authors

Naohiro Kawamura¹, Hiroshi Nakajima, Shin-Ichi Takashi

Affiliation

¹ The Third Department of Internal Medicine, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan.

PMID: 15607138
DOI: 10.1016/j.hepres.2004.10.008

Abstract

The PEM (protein energy malnutrition) is an important factor for improvement of prognosis and QOL in the patients with liver cirrhosis. In 453 chronic liver disease patients, QOL decreased significantly according to the progression of disease assessed by SF-36 (Kruskal-Wallis test: p<0.05) Moreover, the QOL of patients with chronic liver diseases was improved in BCAA administration group (n=13) compared with non-administration group (n=12) after 6 months period. In conclusion, BCAA administration showed improvement of PEM and QOL of patient with chronic liver diseases.